Takeda Pharmaceutical acquires celiac disease drug developer PvP Biologics

Takeda acquisition of PvP Biologics : Japanese pharma giant Takeda Pharmaceutical Company has acquired US-based celiac disease drug developer PvP Biologics in a deal worth ... Read More